Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
SANUWAVE Health
(OTCQB:SNWV)
Intraday
$0.0229
0.0009
[4.09%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0229
0.0009
[4.09%]
At close: May 10
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for SANUWAVE Health Stock (OTC:SNWV)
SANUWAVE Health Stock (OTC: SNWV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 15, 2020
Lake Street Initiates Coverage On SANUWAVE Health with Buy Rating, Announces Price Target of $0.34
Benzinga Newsdesk
-
Sep 15, 2020, 10:21AM
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
-
Mar 24, 2020, 11:35AM
Friday, February 21, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
-
Feb 21, 2020, 10:26AM
Thursday, February 20, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
-
Feb 20, 2020, 10:26AM
Tuesday, February 18, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
-
Feb 18, 2020, 11:03AM
Thursday, February 13, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
-
Feb 13, 2020, 10:26AM
Wednesday, February 12, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
-
Feb 12, 2020, 11:45AM
Tuesday, December 17, 2019
SNWV: U.S. Roll-Out May Be Stronger Than Previously Anticipated
Zacks Small Cap Research
-
Dec 17, 2019, 10:20AM
Tuesday, May 21, 2019
SANUWAVE HEALTH INC by SANUWAVE Health, Inc. Q1 EPS $(0.01), Inline, Sales $177.963K Down From $344.272K YoY
Benzinga Newsdesk
-
May 21, 2019, 8:09AM
Wednesday, May 16, 2018
SANUWAVE HEALTH INC by SANUWAVE Health, Inc. Q1 EPS $(0.04), Made $344.272K Sales
Benzinga
-
May 16, 2018, 8:37AM
Monday, August 14, 2017
Sanuwave Health Reports Q2 EPS $(0.01) vs. $(0.01) In Same Qtr. Last Year, Sales $111K vs. $203K YoY
Benzinga
-
Aug 14, 2017, 5:05PM
Wednesday, July 13, 2011
Rodman & Renshaw Reiterates Market Outperform and PT of $6 on Sanuwave Health
Benzinga
-
Jul 13, 2011, 9:01AM
Tuesday, July 12, 2011
SANUWAVE Announces Positive 24-Week Data from Its Pivotal Trial with dermaPACE for the Treatment of Diabetic Foot Ulcers
Benzinga
-
Jul 12, 2011, 7:08AM
Wednesday, July 06, 2011
SANUWAVE Health Submits Final Module of PMA Application for FDA Approval of dermaPACE
Benzinga
-
Jul 6, 2011, 8:03AM
